Peptide Cost Guide 2026: What You Should Actually Pay

Peptide pricing in 2026 reflects the full landscape: brand-name FDA-approved at the high end, 503A compounded in the middle, research-grade at the bottom, with occasional grey-market outliers below that. Understanding what reasonable pricing looks like is most of how you avoid both overpaying for brand premium and underpaying for substandard product.

This guide is a reference for typical US pricing in early 2026. Numbers shift quarter-to-quarter; treat the ranges as orientations, not quotes.

GLP-1 receptor agonists

The most-prescribed peptide class and the one with the widest price range.

Product	Brand monthly	503A compounded monthly	Research-grade monthly equivalent
Semaglutide	Ozempic: $900–1,000 / Wegovy: $1,000–1,300	$250–500	$50–150 (research only)
Tirzepatide	Mounjaro: $1,000–1,200 / Zepbound: $1,000–1,400	$300–600	$80–200 (research only)
Liraglutide	Saxenda: $900–1,200 / Victoza: $700–900 / generic: $400–700	$200–400	Not commonly research-grade
Retatrutide	Not yet approved	Limited 503A availability	$100–250 (research only)
Cagrilintide	Not yet approved	Limited 503A availability	$80–200 (research only)

Insurance coverage drops monthly cost dramatically for users who qualify — to $25–100/month copay range. The bigger access barrier is qualifying for coverage at all (BMI cutoffs, prior authorization, step therapy).

Outlier signals:

• $50/month research-grade semaglutide is roughly the cost of the active pharmaceutical ingredient at scale. Below that, you're either getting underdosed product or substituted compound.
• $1,500+/month brand pricing happens at retail without insurance and doesn't reflect any quality difference vs $1,000 pricing — it's just channel markup.

Healing peptides

Peptide	Typical research-grade per 5mg vial	Typical research-grade per 10mg vial	Typical monthly cost
BPC-157	$25–45	$40–80	$80–160 (250–500 mcg/day)
TB-500	$40–70	$70–130	$80–150 (loading + maintenance)
Pentosan polysulfate	Limited research-grade availability	—	Brand: $400+/month

Outlier signals:

• BPC-157 below $20/5mg from research-grade vendors typically indicates substituted product or lower-quality synthesis.
• "Ultra-pure" or "pharmaceutical-grade" BPC-157 priced at 2–3× standard rates is mostly marketing — there is no FDA-approved BPC-157 product to be "pharmaceutical-grade" against.

GH-axis peptides

Peptide	Typical research-grade per 5mg	Typical 503A compounded monthly	Typical monthly cost
Sermorelin	— (typically compounded)	$200–400/month	$200–400 (compounded)
CJC-1295/Ipamorelin	$30–60 (combined)	$300–500/month	$80–180 (research-grade) / $300–500 (compounded)
Ipamorelin alone	$25–50	$200–400/month	$60–120 (research-grade)
Tesamorelin	— (Egrifta brand)	$400–600/month	Egrifta brand: $1,200+/month
GHRP-2/GHRP-6	$20–40	Limited compounded	$50–100 (research-grade)
Hexarelin	$30–60	Limited compounded	Cycled use only

Brand vs compounded vs research-grade: GH peptides have a clean three-tier market. Brand exists for Tesamorelin (Egrifta) only; everything else is either compounded through 503A pharmacies or research-grade.

Sexual function peptides

Peptide	Brand pricing	Research-grade per 10mg
PT-141 / Bremelanotide	Vyleesi: $300–500 per as-needed dose pen	$40–80
Melanotan II	Not approved anywhere	$30–60

Outlier signal: Melanotan II priced like a luxury research peptide rarely justifies the markup; it's a relatively simple synthesis. High pricing usually reflects branded packaging rather than quality.

Cognitive / nootropic peptides

Peptide	Typical research-grade pricing	Typical monthly cost
Selank	$30–60 per 5mg	$60–120
Semax	$30–60 per 5mg	$60–120
Cerebrolysin	Brand only: 10× 5mL ampoules ~$250–400	$250–400 per course
Dihexa	$40–80 per 10mg	Variable

Cerebrolysin is regularly imported from Russia or Eastern Europe; pricing reflects shipping and import friction more than synthesis cost.

Cosmetic peptides

These are the cheapest peptide category by a wide margin because they're mass-produced commodity ingredients.

Peptide	Typical formulation pricing
GHK-Cu serums	$20–80 (varies dramatically by brand)
Matrixyl 3000 serums	$15–50
Argireline serums	$15–50
The Ordinary multi-peptide products	$10–30
Premium brand peptide creams	$80–250+

Outlier signal: $200+ peptide creams almost never deliver proportionately more peptide than $30 alternatives. The premium pricing reflects brand, packaging, and additional non-peptide actives — not better peptide concentration or delivery.

Longevity peptides

Peptide	Typical research-grade per 10mg	Typical course cost
Epitalon	$40–80	$100–200 per 10–20 day course
Thymalin	$50–100 (limited supply)	$150–300 per course
Thymosin Alpha-1	$80–160 (research-grade) / Zadaxin brand: $400+/dose	Variable
MOTS-c	$60–120	$200–400/month
SS-31 / elamipretide	$80–160	High — limited research supply
FOXO4-DRI	$200–400	High — niche supply

FOXO4-DRI pricing reflects niche supply, not necessarily better quality. Senolytic peptides are produced in small batches by a small number of synthesizers.

How to think about price per cycle vs price per vial

Comparing peptides by per-vial price misses the actual cost of a protocol. Per-cycle cost is what matters:

Example — BPC-157 4-week cycle:

• 250 mcg subcutaneous twice daily = 500 mcg/day
• 28 days × 500 mcg = 14 mg per cycle
• At $40 per 5 mg vial (research-grade): ~$112 per cycle
• Plus syringes ($15), bacteriostatic water ($10), alcohol swabs and supplies ($5)
• Total: ~$140 per 4-week cycle

Example — CJC-1295/Ipamorelin 12-week protocol:

• 100 mcg CJC + 200 mcg Ipamorelin daily
• 84 days × 300 mcg total = 25.2 mg
• At $50 for 5 mg combined (or buying separately): ~$300 in peptide
• Supplies: ~$30
• Total: ~$330 per 12-week protocol

This frame surfaces the actual cost decision and lets you compare "cost per outcome" rather than "cost per vial."

Where price-quality drops off

For most peptides, price below ~50% of the typical research-grade range is a signal worth investigating before buying. Common explanations for outlier-low pricing:

• Underdosed product (3 mg labeled as 5 mg)
• Substituted product (cheaper peptide labeled as more expensive one)
• Old or improperly stored product
• Vendor running through inventory with quality issues
• Counterfeit or unverified synthesis

Independent third-party testing for $20–50 per sample is the cheapest way to verify before scaling up an order.

Where price-quality drops off the other way

Premium pricing for "pharmaceutical-grade" research peptides is mostly marketing for products without FDA approval. If a vendor is charging 3× normal rates, the burden is on them to demonstrate that quality difference — typically through transparent third-party testing data, not marketing claims.

Bottom line

Reasonable pricing for any peptide class clusters within a 2× range across legitimate vendors. Outliers in either direction need explaining. For FDA-approved peptide medications, the brand-vs-compounded vs research-grade tier structure is real and the price differences reflect real quality and regulatory differences. For research peptides without FDA approval, the price differences are mostly about supply chain, marketing premium, and lot-to-lot consistency, not about a meaningful clinical-grade distinction. Set a reference range, evaluate vendors against it, and be skeptical of both extremes.